ITI Mutual Fund
← All mutual funds

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

ITI Mutual Fund · Sectoral/Thematic · Direct · Growth

NAV · as of 11/09/2026

19.90

1D

-0.30%

1Y

+11.86%

Key stats

Expense ratio
0.98%
AUM
₹262.80 Cr
Launched
11/11/2021
Fund manager
Nilay Dalal; Animesh Singh
Portfolio turnover
0.49%
Risk
Very High Risk
Min lump-sum
₹5,000
Min SIP
₹500/mo
Fresh lump-sum
Accepted
Fresh SIP
Accepted

NAV history

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

13/08/2026 to 11/09/2026

O - H - L -

20.2919.7013/08/202611/09/2026
1W+0.22%
1M-0.16%
3M+8.79%
6M+20.92%
1Y+11.86%
3Y+20.04%
MAX+98.86%

Top holdings

39 disclosed
  • 1.

    Sun Pharmaceuticals Industries Ltd

    Healthcare

    13.26%
  • 2.

    Divi's Laboratories Ltd

    Healthcare

    7.97%
  • 3.

    Apollo Hospitals Enterprise Ltd

    Healthcare

    6.05%
  • 4.

    Max Healthcare Institute Ltd Ordinary Shares

    Healthcare

    5.05%
  • 5.

    Torrent Pharmaceuticals Ltd

    Healthcare

    4.84%
  • 6.

    Cipla Ltd

    Healthcare

    4.43%
  • 7.

    Dr Reddy's Laboratories Ltd

    Healthcare

    4.41%
  • 8.

    Laurus Labs Ltd

    Healthcare

    4.21%
  • 9.

    Aurobindo Pharma Ltd

    Healthcare

    3.84%
  • 10.

    Mankind Pharma Ltd

    Healthcare

    3.39%
  • 11.

    Cohance Lifesciences Ltd

    Healthcare

    3.04%
  • 12.

    Neuland Laboratories Ltd

    Healthcare

    3.03%
  • 13.

    Global Health Ltd

    Healthcare

    2.98%
  • 14.

    Alkem Laboratories Ltd

    Healthcare

    2.92%
  • 15.

    Lupin Ltd

    Healthcare

    2.82%
  • 16.

    Fortis Healthcare Ltd

    Healthcare

    2.79%
  • 17.

    Net Receivables / (Payables)

    2.12%
  • 18.

    Abbott India Ltd

    Healthcare

    1.90%
  • 19.

    Poly Medicure Ltd

    Healthcare

    1.52%
  • 20.

    Ipca Laboratories Ltd

    Healthcare

    1.50%
  • 21.

    Aster DM Quality Care Ltd Ordinary Shares

    Healthcare

    1.35%
  • 22.

    Sai Life Sciences Ltd

    Healthcare

    1.32%
  • 23.

    Piramal Pharma Ltd

    Healthcare

    1.27%
  • 24.

    Shaily Engineering Plastics Ltd

    Basic Materials

    1.23%
  • 25.

    HealthCare Global Enterprises Ltd

    Healthcare

    1.21%
  • 26.

    Shilpa Medicare Ltd

    Healthcare

    1.15%
  • 27.

    Linde India Ltd

    Basic Materials

    1.10%
  • 28.

    Glenmark Pharmaceuticals Ltd

    Healthcare

    1.09%
  • 29.

    Rainbow Childrens Medicare Ltd

    Healthcare

    1.05%
  • 30.

    Biocon Ltd

    Healthcare

    0.95%
  • 31.

    GlaxoSmithKline Pharmaceuticals Ltd

    Healthcare

    0.93%
  • 32.

    Supriya Lifescience Ltd

    Healthcare

    0.92%
  • 33.

    Medplus Health Services Ltd

    Healthcare

    0.88%
  • 34.

    Zydus Lifesciences Ltd

    Healthcare

    0.72%
  • 35.

    Venus Pipes & Tubes Ltd

    Basic Materials

    0.69%
  • 36.

    Syngene International Ltd

    Healthcare

    0.61%
  • 37.

    Caplin Point Laboratories Ltd

    Healthcare

    0.54%
  • 38.

    Bharat Dynamics Ltd Ordinary Shares

    Industrials

    0.47%
  • 39.

    Yes Bank Ltd

    Financial Services

    0.46%

Sector allocation

  • Healthcare93.92%
  • Basic Materials3.03%
  • Unclassified2.12%
  • Industrials0.47%
  • Financial Services0.46%

Comparable peers

  • SBI Healthcare Opportunities Growth Direct Plan

    SBI Healthcare Opportunities (G) · ₹5.80 K Cr AUM

    1Y+21.41%
    3Y+24.25%
    -

  • UTI Healthcare Growth Direct Plan

    UTI Healthcare (G) · ₹1.44 K Cr AUM

    1Y+16.47%
    3Y+24.12%
    -

  • LIC MF Infrastructure Growth Direct Plan

    LIC MF Infrastructure (G) · ₹1.17 K Cr AUM

    1Y+12.15%
    3Y+23.06%
    -

  • ITI Pharma & Healthcare Growth Direct Plan

    ITI Pharma & Healthcare (G) · ₹262.80 Cr AUM

    1Y+11.86%
    3Y+19.81%
    -

  • HDFC Transportation & Logistics Growth Direct Plan

    HDFC Transportation & Logistics (G) · ₹2.12 K Cr AUM

    1Y+9.75%
    3Y+24.94%
    -

Investment objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Scheme details

Scheme code
149268
Fund house
ITI Mutual Fund
Category
Open Ended
Type
Equity Scheme
Sub-category
Sectoral/Thematic
Plan
Direct
Return type
Growth
ISIN (Growth)
INF00XX01BO9
ISIN (Div. Reinvest)
-
Tradable on exchange
No

Kuvera page